The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Kelly A MetcalfeJacek GronwaldNadine M TungJeanna M McCuaigAndrea EisenChristine ElserWilliam D FoulkesSusan L NeuhausenLeigha SenterPal MollerLouise BordeleauRobert FruscioLea VelsherDana ZakalikOlufunmilayo I OlopadeCharis EngTuya PalCarey A CullinaneFergus J CouchJoanne KotsopoulosPing SunJan LubinskiSteven A NarodPublished in: Cancer (2022)
Women with a BRCA1 or BRCA2 pathogenic variant have a high risk of cancer between the ages of 50 and 75 years and should be counselled appropriately.